Dabrafenib alters MDSC differentiation and function by activation of GCN2
M. T. Ciudad, R. Quevedo, S. Lamorte, R. Jin, N. Nzirorera, M. Koritzinsky, T. L. McGaha
This study shows that dabrafenib inhibits PMN-MDSC differentiation via GCN2 activation, altering their function and reducing their suppressive activity in tumors.
bioRxiv · Aug 9, 2023Immunology